• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管疾病重塑的病理生理特征:DNA结合/分化抑制因子3与雌激素类内分泌干扰物的影响

Pathophysiological Features of Remodeling in Vascular Diseases: Impact of Inhibitor of DNA-Binding/Differentiation-3 and Estrogenic Endocrine Disruptors.

作者信息

Avecilla Vincent, Doke Mayur, Appunni Sandeep, Rubens Muni, Ramamoorthy Venkataraghavan, Das Jayanta Kumar

机构信息

Robert Stempel College of Public Health & Social Work, Florida International University, Miami, FL 33199, USA.

Avecilla Consulting LLC, Miami, FL 33131, USA.

出版信息

Med Sci (Basel). 2024 Dec 26;13(1):2. doi: 10.3390/medsci13010002.

DOI:10.3390/medsci13010002
PMID:39846697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11755649/
Abstract

Vascular diseases, such as hypertension, atherosclerosis, cerebrovascular, and peripheral arterial diseases, present major clinical and public health challenges, largely due to their common underlying process: vascular remodeling. This process involves structural alterations in blood vessels, driven by a variety of molecular mechanisms. The inhibitor of DNA-binding/differentiation-3 (), a crucial member of ID family of transcriptional regulators, has been identified as a key player in vascular biology, significantly impacting the progression of these diseases. This review explores the role of in vascular remodeling, emphasizing its involvement in processes such as apoptosis, cell proliferation, and extracellular matrix regulation. Furthermore, we examine how oxidative stress, intensified by exposure to estrogenic endocrine disruptors (EEDs) like polychlorinated biphenyls (PCBs) and bisphenol A (BPA), affects activity and contributes to vascular disease. Understanding the interaction between signaling and EED exposure provides critical insights into the molecular mechanisms underlying vascular remodeling and its role in the development and progression of vascular diseases.

摘要

血管疾病,如高血压、动脉粥样硬化、脑血管疾病和外周动脉疾病,构成了重大的临床和公共卫生挑战,这主要是由于它们共同的潜在过程:血管重塑。这个过程涉及血管的结构改变,由多种分子机制驱动。DNA结合/分化抑制因子3(ID3)是转录调节因子ID家族的关键成员,已被确定为血管生物学中的关键角色,对这些疾病的进展有重大影响。本综述探讨了ID3在血管重塑中的作用,强调其参与凋亡、细胞增殖和细胞外基质调节等过程。此外,我们研究了暴露于多氯联苯(PCBs)和双酚A(BPA)等雌激素内分泌干扰物(EEDs)所加剧的氧化应激如何影响ID3活性并导致血管疾病。了解ID3信号传导与EED暴露之间的相互作用,为深入了解血管重塑的分子机制及其在血管疾病发生和发展中的作用提供了关键见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e31/11755649/e94dbede40b1/medsci-13-00002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e31/11755649/fbad4d1b1246/medsci-13-00002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e31/11755649/9a8284e3f7ab/medsci-13-00002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e31/11755649/e94dbede40b1/medsci-13-00002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e31/11755649/fbad4d1b1246/medsci-13-00002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e31/11755649/9a8284e3f7ab/medsci-13-00002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e31/11755649/e94dbede40b1/medsci-13-00002-g003.jpg

相似文献

1
Pathophysiological Features of Remodeling in Vascular Diseases: Impact of Inhibitor of DNA-Binding/Differentiation-3 and Estrogenic Endocrine Disruptors.血管疾病重塑的病理生理特征:DNA结合/分化抑制因子3与雌激素类内分泌干扰物的影响
Med Sci (Basel). 2024 Dec 26;13(1):2. doi: 10.3390/medsci13010002.
2
Integrative Bioinformatics-Gene Network Approach Reveals Linkage between Estrogenic Endocrine Disruptors and Vascular Remodeling in Peripheral Arterial Disease.整合生物信息学-基因网络方法揭示了雌激素内分泌干扰物与外周动脉疾病血管重塑之间的联系。
Int J Mol Sci. 2024 Apr 19;25(8):4502. doi: 10.3390/ijms25084502.
3
Inhibitor of Differentiation-3 and Estrogenic Endocrine Disruptors: Implications for Susceptibility to Obesity and Metabolic Disorders.分化抑制因子-3 和雌激素类内分泌干扰物:对肥胖和代谢紊乱易感性的影响。
Biomed Res Int. 2018 Jan 8;2018:6821601. doi: 10.1155/2018/6821601. eCollection 2018.
4
Estrogenic Endocrine Disrupting Chemicals Influencing NRF1 Regulated Gene Networks in the Development of Complex Human Brain Diseases.影响复杂人类脑部疾病发展中NRF1调控基因网络的雌激素类内分泌干扰化学物质。
Int J Mol Sci. 2016 Dec 13;17(12):2086. doi: 10.3390/ijms17122086.
5
Contribution of Inhibitor of DNA Binding/Differentiation-3 and Endocrine Disrupting Chemicals to Pathophysiological Aspects of Chronic Disease.DNA结合/分化抑制因子3及内分泌干扰化学物质对慢性疾病病理生理方面的作用
Biomed Res Int. 2017;2017:6307109. doi: 10.1155/2017/6307109. Epub 2017 Jul 13.
6
Environmental estrogen-like endocrine disrupting chemicals and breast cancer.环境雌激素样内分泌干扰化学物质与乳腺癌。
Mol Cell Endocrinol. 2017 Dec 5;457:89-102. doi: 10.1016/j.mce.2016.10.003. Epub 2016 Oct 4.
7
Exploring the impact of estrogenic endocrine disruptors on cervical cancer progression: A transcriptome analysis and prognostic model development.探讨雌激素内分泌干扰物对宫颈癌进展的影响:转录组分析与预后模型的建立。
Ecotoxicol Environ Saf. 2024 Oct 15;285:117025. doi: 10.1016/j.ecoenv.2024.117025. Epub 2024 Sep 19.
8
Microvascular lesions by estrogen-induced ID3: its implications in cerebral and cardiorenal vascular disease.雌激素诱导的ID3所致微血管病变:其在脑和心肾血管疾病中的意义
J Mol Neurosci. 2015 Mar;55(3):618-31. doi: 10.1007/s12031-014-0401-9. Epub 2014 Aug 17.
9
Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells.Id 蛋白是 BMP 信号在人肺动脉平滑肌细胞中的关键下游效应因子。
Am J Physiol Lung Cell Mol Physiol. 2013 Aug 15;305(4):L312-21. doi: 10.1152/ajplung.00054.2013. Epub 2013 Jun 14.
10
A negative correlation between insulin-like peptide 3 and bisphenol A in human cord blood suggests an effect of endocrine disruptors on testicular descent during fetal development.胰岛素样肽 3 与人类脐血中双酚 A 之间呈负相关,提示内分泌干扰物对胎儿发育过程中睾丸下降的影响。
Hum Reprod. 2015 Feb;30(2):447-53. doi: 10.1093/humrep/deu340. Epub 2014 Dec 19.

本文引用的文献

1
Liver and Pancreatic Toxicity of Endocrine-Disruptive Chemicals: Focus on Mitochondrial Dysfunction and Oxidative Stress.内分泌干扰化学物的肝和胰腺毒性:聚焦于线粒体功能障碍和氧化应激。
Int J Mol Sci. 2024 Jul 6;25(13):7420. doi: 10.3390/ijms25137420.
2
Data-driven derivation of an adverse outcome pathway linking vascular endothelial growth factor receptor (VEGFR), endocrine disruption, and atherosclerosis.基于数据的血管内皮生长因子受体(VEGFR)、内分泌干扰和动脉粥样硬化不良结局途径推导。
ALTEX. 2024;41(4):617-632. doi: 10.14573/altex.2403211. Epub 2024 Jul 8.
3
Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation.
心血管疾病中的血管重构:高血压、氧化和炎症。
Clin Sci (Lond). 2024 Jul 3;138(13):817-850. doi: 10.1042/CS20220797.
4
Stress, Vascular Smooth Muscle Cell Phenotype and Atherosclerosis: Novel Insight into Smooth Muscle Cell Phenotypic Transition in Atherosclerosis.应激、血管平滑肌细胞表型与动脉粥样硬化:动脉粥样硬化中平滑肌细胞表型转变的新认识。
Curr Atheroscler Rep. 2024 Aug;26(8):411-425. doi: 10.1007/s11883-024-01220-8. Epub 2024 May 30.
5
Integrative Bioinformatics-Gene Network Approach Reveals Linkage between Estrogenic Endocrine Disruptors and Vascular Remodeling in Peripheral Arterial Disease.整合生物信息学-基因网络方法揭示了雌激素内分泌干扰物与外周动脉疾病血管重塑之间的联系。
Int J Mol Sci. 2024 Apr 19;25(8):4502. doi: 10.3390/ijms25084502.
6
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据:美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
7
The role of angiotensin II activation of yes-associated protein/PDZ-binding motif signaling in hypertensive cardiac and vascular remodeling.血管紧张素 II 激活 yes 相关蛋白/PDZ 结合基序信号在高血压心脏和血管重构中的作用。
Eur J Pharmacol. 2024 Jan 5;962:176252. doi: 10.1016/j.ejphar.2023.176252. Epub 2023 Dec 5.
8
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHD.组织浸润性同种反应性 T 细胞在移植物抗宿主病中需要 ID3 来规避 PD-1 介导的免疫抑制。
Blood. 2024 Jan 11;143(2):166-177. doi: 10.1182/blood.2023021126.
9
β1 integrin is essential for blood-brain barrier integrity under stable and vascular remodelling conditions; effects differ with age.β1 整合素对于稳定和血管重塑条件下的血脑屏障完整性是必需的;其作用随年龄而不同。
Fluids Barriers CNS. 2023 Jul 3;20(1):52. doi: 10.1186/s12987-023-00453-0.
10
Endocrine-Disrupting Chemicals and Disease Endpoints.内分泌干扰化学物质与疾病终点
Int J Mol Sci. 2023 Mar 10;24(6):5342. doi: 10.3390/ijms24065342.